Evidence reviewed July 13, 2026

Ingredient lists can reveal as much about a formula as the ingredients intentionally left out. DIM appears in many supplements marketed for “estrogen detox” and hormone balance, but we chose not to include it in WrenLife Hormone Health.

That decision was not because DIM is inherently bad. DIM is biologically active and can change how the body metabolizes estrogen—but that does not make it appropriate for everyone. The clinical evidence remains limited, individual hormone needs differ, and DIM may affect certain medications and hormone therapies.

For us, the question was not simply, “Can DIM do something?” It was, “Does DIM belong as a default ingredient in a daily formula intended for a broad group of women?” Based on the available evidence, we decided it did not. This article explains why biologically active does not mean universally appropriate.

What is DIM?

DIM stands for 3,3′-diindolylmethane. When cruciferous vegetables are chopped or chewed, compounds in the plant can give rise to indole-3-carbinol. In the acidic environment of the stomach, indole-3-carbinol forms several products, including DIM.¹

That food origin is real, but it can also be misleading. A concentrated DIM supplement delivers a standardized dose—sometimes in a formulation designed to increase absorption. Whole cruciferous vegetables provide fiber, vitamins, minerals, and many plant compounds, and the amount of DIM formed after eating them varies. A supplement should not be treated as nutritionally interchangeable with the vegetable it came from.^{1, 2}

What does DIM do to estrogen metabolism?

Estrogen is not one molecule following one pathway. Estrone and estradiol are converted into multiple metabolites, which are then further processed and eliminated. DIM can influence the relative amounts of some of those measured metabolites.

In a 12-month randomized trial, 130 women prescribed tamoxifen were assigned to an absorption-enhanced DIM product at 150 mg twice daily or placebo. DIM increased the urinary ratio of 2-hydroxyestrone to 16α-hydroxyestrone and increased sex hormone-binding globulin. It did not change breast density, the study’s tissue-related outcome.³

Another randomized trial enrolled 60 premenopausal women with a low baseline estrogen-metabolite ratio. A lower DIM dose taken for 30 days did not significantly increase that ratio at the end of supplementation.⁴ Retrospective laboratory-database studies have also reported differences in urinary estrogen profiles among DIM users, but those studies did not establish a dose, control adherence, or show that the laboratory changes improved symptoms or health outcomes.^{5, 6}

Why “estrogen detox” is not an accurate summary

DIM is often described online as helping the body make more “good estrogen” and less “bad estrogen.” That language turns a complex metabolic network into a simple score—and the clinical evidence does not support that certainty.

The 2-hydroxyestrone-to-16α-hydroxyestrone ratio became popular as a possible marker of breast-cancer risk. However, a systematic review of nine studies found that prospective evidence did not support using this ratio as a predictive marker for breast-cancer risk.⁷ Raising a ratio should therefore not be presented as proof of “detoxification,” cancer prevention, or better hormone health.

Estrogen metabolites are not household toxins, and a single urinary ratio is not a diagnosis of “estrogen dominance.” If symptoms suggest a gynecologic, endocrine, or metabolic issue, the appropriate next step is a real clinical evaluation—not an assumption that estrogen needs to be “cleared.”

What has DIM actually been shown to improve?

The strongest conclusion is narrower than many supplement claims: DIM can change certain hormone-related biomarkers in some people and at some doses.

It has not been established as a treatment for PMS, acne, PCOS/PMOS, endometriosis, uterine fibroids, infertility, menopausal symptoms, or cancer. One frequently cited endometriosis report included only eight women who received either dienogest alone or dienogest plus DIM for three months. Because it was tiny and DIM was added to prescription therapy, it cannot establish DIM as an effective endometriosis treatment.⁸ A 2026 critical review likewise concluded that evidence for dietary supplements in endometriosis was insufficient for treatment recommendations.¹²

Clinical outcomes do not always follow promising laboratory findings. In a double-blind randomized trial of 551 women with low-grade cervical-cell abnormalities, six months of DIM was well tolerated but did not improve cervical cytology or HPV infection.⁹

This does not mean DIM can never be useful. It means the reason for taking it should be specific, the expected outcome should be clear, and the evidence should match that outcome.

Why DIM does not fit everyone

1. Not everyone needs the same estrogen-related intervention

Similar symptoms can have very different causes. Acne, irregular bleeding, breast tenderness, fatigue, mood changes, or changes in cycle length do not prove that estrogen is “too high” or that one metabolic pathway needs to be pushed in a different direction.

Hormone exposure and goals also differ across life stages. A person using menopausal hormone therapy, someone trying to conceive, and someone taking tamoxifen should not be given the same blanket supplement advice.

2. DIM may affect medication metabolism

In the 12-month tamoxifen trial, DIM lowered plasma concentrations of endoxifen, 4-hydroxytamoxifen, and N-desmethyltamoxifen. The clinical significance remains uncertain, but endoxifen is an active tamoxifen metabolite. Anyone taking tamoxifen should involve their oncology team before considering DIM.³

Laboratory research using human liver and intestinal cells also found that DIM activated the pregnane X receptor and increased expression of CYP3A4 and the drug transporter MDR1. This creates a plausible interaction concern, but it does not prove that DIM reduces the effectiveness of every medication processed through those pathways.¹⁰ A pharmacist or prescriber can assess the actual medication list.

A 2025 retrospective study found altered urinary estrogen profiles among postmenopausal women who reported using both DIM and a transdermal estradiol patch. The study did not measure symptom control, bone density, or a defined DIM dose, so the clinical effect is unknown. It is still a useful reason to tell a hormone-therapy prescriber about DIM use.⁶

3. Short-term tolerability does not answer every safety question

In a small single-dose study of healthy adults, absorption-enhanced DIM was well tolerated through 200 mg; at 300 mg, nausea, headache, and vomiting were reported in two of six participants.² In the 12-month tamoxifen trial, overall adverse-event rates did not differ between groups, although discolored urine was reported by 40% of DIM participants.³

Those findings are somewhat reassuring, but they do not establish long-term safety for every population, dose, or formulation. Safety of concentrated DIM supplementation during pregnancy and breastfeeding has not been established. Memorial Sloan Kettering advises against DIM use during pregnancy, while trying to conceive, or while nursing because of its potential hormonal effects.¹¹

Why we did not include DIM in Hormone Health

Our formulation decision came down to three questions:

1. Is the ingredient appropriate as a default? DIM changes estrogen metabolism, but that is not a universal need.
2. Do human trials show the outcomes our customers are usually seeking? The evidence is still centered on metabolites and other biomarkers, not consistent improvement in everyday hormone-related symptoms.
3. Can the ingredient complicate medication or hormone-therapy decisions? DIM has enough interaction potential that individual review matters.

For those reasons, we chose not to build a targeted estrogen-metabolism intervention into a broad daily formula. We believe DIM is better considered separately, for a defined reason and with professional guidance when appropriate.

Leaving DIM out does not mean DIM is harmful, and it does not mean Hormone Health is appropriate for everyone. It means we kept the formula aligned with its intended scope instead of adding a popular ingredient simply because it appears on many “hormone balance” lists.

What is in WrenLife Hormone Health?

WrenLife Hormone Health contains myo-inositol and D-chiro-inositol in a 40:1 ratio, whey protein isolate (90% alpha-lactalbumin; contains milk), vitamin D3, vitamin K2, magnesium, chromium, and zinc. It is designed to complement a general wellness routine.*

Research on an individual ingredient should not be interpreted as proof that a finished multi-ingredient product produces the same clinical result. Hormone Health is not intended to diagnose, treat, cure, or prevent PCOS/PMOS, infertility, acne, endometriosis, fibroids, diabetes, or any other disease.

Before use: Hormone Health is not intended for use during pregnancy or while breastfeeding. Review the current Supplement Facts and allergen statement. Do not use it if you have a milk-protein allergy or a known hypersensitivity to an ingredient. If you have a medical condition or take medication, consult a healthcare professional before use. Because the formula contains vitamin K2, this is especially important if you take warfarin or a similar vitamin-K antagonist.

View Hormone Health ingredients, Supplement Facts, and use information →

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Questions to ask before taking DIM

• What specific outcome am I trying to improve?
• Is that outcome supported by human clinical research, or only by a metabolite change?
• Could my symptoms have another cause that should be evaluated?
• Could DIM interact with tamoxifen, hormone therapy, hormonal contraception, or another medication I take?
• What dose and formulation were studied for this exact purpose?
• How long would I use it, and how would we know whether it is helping?

Frequently asked questions

Is DIM bad for you?

Not necessarily. Human studies suggest that DIM is reasonably well tolerated in several studied settings. But it is biologically active, long-term outcome data are limited, and medication and hormone-therapy context matters. “Not right for everyone” is more accurate than either “bad” or “safe for everyone.”

Does DIM lower estrogen?

That is too simple. DIM can change the relative amounts of several estrogen metabolites and may affect other hormone-related measurements. Its effect depends on the person, dose, formulation, and what is being measured. It should not be described as a predictable estrogen-lowering supplement.

Does DIM detox excess estrogen?

“Estrogen detox” is a marketing phrase, not a demonstrated clinical outcome. DIM can alter estrogen-metabolite patterns, but a higher 2-to-16 ratio has not been validated as proof of better health or lower breast-cancer risk.⁷

Can DIM treat hormonal acne, PCOS/PMOS, fibroids, or endometriosis?

Current human evidence does not establish DIM as a treatment for these conditions. These concerns have different causes and evidence-based care options; a targeted evaluation is more appropriate than assuming all are caused by “excess estrogen.”

Can I take DIM with birth control or menopausal hormone therapy?

Do not assume there is no interaction. Direct clinical evidence with hormonal contraception is limited, so it would be inaccurate to say DIM definitely makes birth control ineffective. Because DIM can alter estrogen metabolism and has laboratory evidence of effects on drug-metabolizing pathways, review it with your prescriber or pharmacist. People using menopausal hormone therapy should also disclose DIM use.^{6, 10, 11}

Can I take a separate DIM product with Hormone Health?

We cannot determine that from the product names alone. A healthcare professional or pharmacist should review your goals, medications, hormone therapies, medical history, and both complete labels before you combine supplements.

The bottom line

DIM is a real, biologically active compound—not a meaningless ingredient. But its ability to alter estrogen metabolites is exactly why it should not be treated as a universal answer to every hormone-related concern.

We did not include DIM in Hormone Health because the clinical benefits are not established for a broad daily-use population, individual hormone goals differ, and medication context matters. That is a decision about formulation fit and evidence—not a claim that no one should ever use DIM.

This article is for educational purposes and is not medical advice. DIM supplements may affect estrogen metabolism and may interact with medications. Consult a qualified healthcare professional before using DIM, especially if you take tamoxifen or another prescription medicine, use hormone therapy or hormonal contraception, are pregnant or breastfeeding, are trying to conceive, have a hormone-sensitive condition, or are receiving cancer treatment. Do not stop or change prescribed treatment based on this article.

Scientific references

1. Fujioka N, Ransom BW, Carmella SG, et al. Harnessing the Power of Cruciferous Vegetables: Developing a Biomarker for Brassica Vegetable Consumption Using Urinary 3,3′-Diindolylmethane. Cancer Prevention Research. 2016;9(10):788–793. doi:10.1158/1940-6207.CAPR-16-0136.
2. Reed GA, Sunega JM, Sullivan DK, et al. Single-dose pharmacokinetics and tolerability of absorption-enhanced 3,3′-diindolylmethane in healthy subjects. Cancer Epidemiology, Biomarkers & Prevention. 2008;17(10):2619–2624. doi:10.1158/1055-9965.EPI-08-0520.
3. Thomson CA, Chow HHS, Wertheim BC, et al. A randomized, placebo-controlled trial of diindolylmethane for breast cancer biomarker modulation in patients taking tamoxifen. Breast Cancer Research and Treatment. 2017;165(1):97–107. doi:10.1007/s10549-017-4292-7.
4. Godínez-Martínez E, Santillán R, Sámano R, et al. Effectiveness of 3,3′-Diindolylmethane Supplements on Favoring the Benign Estrogen Metabolism Pathway and Decreasing Body Fat in Premenopausal Women. Nutrition and Cancer. 2023;75(2):510–519. doi:10.1080/01635581.2022.2123535.
5. Newman M, Smeaton J. Exploring the impact of 3,3′-diindolylmethane on the urinary estrogen profile of premenopausal women. BMC Complementary Medicine and Therapies. 2024;24:405. doi:10.1186/s12906-024-04708-7.
6. Newman MS, Smeaton J. The impact of 3,3′-diindolylmethane on estradiol and estrogen metabolism in postmenopausal women using a transdermal estradiol patch. Menopause. 2025;32(7):630–639. doi:10.1097/GME.0000000000002542.
7. Obi N, Vrieling A, Heinz J, Chang-Claude J. Estrogen metabolite ratio: Is the 2-hydroxyestrone to 16α-hydroxyestrone ratio predictive for breast cancer? International Journal of Women’s Health. 2011;3:37–51. doi:10.2147/IJWH.S7595.
8. Morales-Prieto DM, Herrmann J, Osterwald H, et al. Comparison of dienogest effects upon 3,3′-diindolylmethane supplementation in models of endometriosis and clinical cases. Reproductive Biology. 2018;18(3):252–258. doi:10.1016/j.repbio.2018.07.002.
9. Castañon A, Tristram A, Mesher D, et al. Effect of diindolylmethane supplementation on low-grade cervical cytological abnormalities: double-blind, randomised, controlled trial. British Journal of Cancer. 2012;106(1):45–52. doi:10.1038/bjc.2011.496.
10. Pondugula SR, Flannery PC, Abbott KL, et al. Diindolylmethane, a naturally occurring compound, induces CYP3A4 and MDR1 gene expression by activating human PXR. Toxicology Letters. 2015;232(3):580–589. doi:10.1016/j.toxlet.2014.12.015.
11. Memorial Sloan Kettering Cancer Center. Diindolylmethane. About Herbs, Botanicals & Other Products. Accessed July 13, 2026.
12. Wójtowicz M, Małek P, Olszanecka-Glinianowicz M. The Role of Dietary Supplements in the Treatment of Endometriosis: A Critical Review. Nutrients. 2026;18(8):1274. doi:10.3390/nu18081274.